Contribution margin recovery
Identify gross-margin, CAC, fulfilment, inventory and channel leaks that prevent profitable scale.
Explore margin recoverySolutions
Move the metric that matters.
Commercial outcomes first. Proprietary frameworks second. Every pathway is designed to reduce risk, improve margin, accelerate innovation or strengthen enterprise value.
Commercial intent first
Choose the problem that must move.
Each pathway begins with a measurable business outcome and then applies the relevant Biological Executive Intelligence framework.
CDMO strategy and technical due diligence
Assess formulation capability, scale-up risk, quality systems, transfer readiness and commercialization discipline.
De-risk the CDMO decisionInnovation and R&D transformation
Improve portfolio choice, cycle time, hit rate, platform design and scientific organisation capability.
Build the innovation systemPE and board value creation
Strengthen technical diligence, capital allocation, innovation governance and post-acquisition integration.
Explore institutional advisoryBeauty and consumer-health scale-up
Translate science, consumer insight and premium architecture into defensible categories and durable margins.
Explore global R&D advisoryExecutive and biological coherence
Build leadership environments that protect judgment, recovery, attention and long-term execution quality.
Explore Biological Leadership™